"ASPR1," is a protein whose name suggests the presence of an aspartate-rich (Asp-rich) domain. While the exact functions and characteristics of ASPR1 may not be well-documented or entirely understood, we can infer possible roles based on the common features of aspartate-rich motifs in proteins.Aspartate-rich motifs are known to participate in the catalytic functions of several types of enzymes, such as those involved in the non-oxidative phase of the pentose phosphate pathway and the biosynthesis of amino acids and nucleotides. The aspartate residues typically contribute to the binding of substrates or cofactors, and they may be involved in the catalytic mechanism itself, often by stabilizing charged intermediates during enzymatic reactions.
Given its name, ASPR1 might function as an enzyme or a binding protein where the aspartate-rich region plays a crucial role in the interaction with other molecules. This could allow ASPR1 to be involved in a variety of metabolic or signaling pathways, depending on its specific structure and the cellular context.In proteins where aspartate-rich domains are found, they often chelate metal ions that are necessary for enzymatic activity or facilitate the formation of protein complexes. Therefore, ASPR1 might also have a role in metal ion homeostasis or signaling pathways that are regulated by metal ion-dependent conformational changes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib inhibits the proteasome, potentially impacting protein degradation processes relevant to ASPR1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR signaling, which can impact protein synthesis and potentially influence ASPR1 functions. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylases, potentially affecting gene expression and influencing ASPR1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibitors of the MAPK/ERK pathway might influence signaling pathways relevant to the function of ASPR1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibitors of the PI3K/Akt pathway might impact signaling pathways relevant to ASPR1. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Inhibiting NF-κB signaling might indirectly influence ASPR1 activity if it's involved in related pathways. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $246.00 $490.00 $536.00 | 16 | |
Inhibitors of JAK/STAT signaling might indirectly influence ASPR1 if it's involved in these pathways. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Calcium channel blockers might impact cellular signaling and processes relevant to ASPR1. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporine A inhibits calcineurin, affecting signal transduction pathways that could influence ASPR1. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1 inhibits lysosomal function, which could impact cellular pathways involving ASPR1. |